China Anti-Ageing Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Anti-aging drugs are used to combat life-saving factors caused by the continuous production of free radicals in the human body due to continuous contact with the outside world, including respiration (oxidation reaction), external pollution, radiation exposure and other factors.

    Although aging is a natural phenomenon that cannot be avoided, following certain principles and using certain methods can achieve the purpose of delaying the occurrence of aging.

    The growth of the global anti-aging drug market is driven by factors such as the growth of the elderly population, the growth of demand for anti-aging drugs, and the influence of the media and fashion industries. Due to the increasing awareness of the use of anti-aging products among the middle-aged and elderly population, the global anti-aging drug market will have huge growth potential in the next few years.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Anti-Ageing Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Anti-Ageing Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Anti-Ageing Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • BIOTIME

    • La Roche-Posay

    • Elysium Health

    • Nu Skin

    • DermaFix

    By Type:

    • Hormonal Therapy

    • Antioxidants

    • Enzymes

    • Stem Cells

    • Others

    By End-User:

    • Skin

    • Hair

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-Ageing Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Anti-Ageing Drugs Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027

    • 1.3.2 China Anti-Ageing Drugs Market Size and Growth Rate of Antioxidants from 2016 to 2027

    • 1.3.3 China Anti-Ageing Drugs Market Size and Growth Rate of Enzymes from 2016 to 2027

    • 1.3.4 China Anti-Ageing Drugs Market Size and Growth Rate of Stem Cells from 2016 to 2027

    • 1.3.5 China Anti-Ageing Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Anti-Ageing Drugs Market Size and Growth Rate of Skin from 2016 to 2027

    • 1.4.2 China Anti-Ageing Drugs Market Size and Growth Rate of Hair from 2016 to 2027

    • 1.4.3 China Anti-Ageing Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Anti-Ageing Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Anti-Ageing Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Hormonal Therapy

    • 3.4.2 Market Size and Growth Rate of Antioxidants

    • 3.4.3 Market Size and Growth Rate of Enzymes

    • 3.4.4 Market Size and Growth Rate of Stem Cells

    • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Anti-Ageing Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Anti-Ageing Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Anti-Ageing Drugs in Skin

    • 4.4.2 Market Size and Growth Rate of Anti-Ageing Drugs in Hair

    • 4.4.3 Market Size and Growth Rate of Anti-Ageing Drugs in Others

    5 Market Analysis by Regions

    • 5.1 China Anti-Ageing Drugs Production Analysis by Regions

    • 5.2 China Anti-Ageing Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Anti-Ageing Drugs Landscape Analysis

    • 6.1 North China Anti-Ageing Drugs Landscape Analysis by Major Types

    • 6.2 North China Anti-Ageing Drugs Landscape Analysis by Major End-Users

    7 Central China Anti-Ageing Drugs Landscape Analysis

    • 7.1 Central China Anti-Ageing Drugs Landscape Analysis by Major Types

    • 7.2 Central China Anti-Ageing Drugs Landscape Analysis by Major End-Users

    8 South China Anti-Ageing Drugs Landscape Analysis

    • 8.1 South China Anti-Ageing Drugs Landscape Analysis by Major Types

    • 8.2 South China Anti-Ageing Drugs Landscape Analysis by Major End-Users

    9 East China Anti-Ageing Drugs Landscape Analysis

    • 9.1 East China Anti-Ageing Drugs Landscape Analysis by Major Types

    • 9.2 East China Anti-Ageing Drugs Landscape Analysis by Major End-Users

    10 Northeast China Anti-Ageing Drugs Landscape Analysis

    • 10.1 Northeast China Anti-Ageing Drugs Landscape Analysis by Major Types

    • 10.2 Northeast China Anti-Ageing Drugs Landscape Analysis by Major End-Users

    11 Southwest China Anti-Ageing Drugs Landscape Analysis

    • 11.1 Southwest China Anti-Ageing Drugs Landscape Analysis by Major Types

    • 11.2 Southwest China Anti-Ageing Drugs Landscape Analysis by Major End-Users

    12 Northwest China Anti-Ageing Drugs Landscape Analysis

    • 12.1 Northwest China Anti-Ageing Drugs Landscape Analysis by Major Types

    • 12.2 Northwest China Anti-Ageing Drugs Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 BIOTIME

      • 13.1.1 BIOTIME Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 La Roche-Posay

      • 13.2.1 La Roche-Posay Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Elysium Health

      • 13.3.1 Elysium Health Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Nu Skin

      • 13.4.1 Nu Skin Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 DermaFix

      • 13.5.1 DermaFix Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Antioxidants from 2016 to 2027

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Enzymes from 2016 to 2027

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Stem Cells from 2016 to 2027

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Skin from 2016 to 2027

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Hair from 2016 to 2027

    • Figure China Anti-Ageing Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Anti-Ageing Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Anti-Ageing Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Anti-Ageing Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Anti-Ageing Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Anti-Ageing Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Hormonal Therapy

    • Figure Market Size and Growth Rate of Antioxidants

    • Figure Market Size and Growth Rate of Enzymes

    • Figure Market Size and Growth Rate of Stem Cells

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Anti-Ageing Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Anti-Ageing Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Skin

    • Figure Market Size and Growth Rate of Hair

    • Figure Market Size and Growth Rate of Others

    • Table China Anti-Ageing Drugs Production by Regions

    • Table China Anti-Ageing Drugs Production Share by Regions

    • Figure China Anti-Ageing Drugs Production Share by Regions in 2016

    • Figure China Anti-Ageing Drugs Production Share by Regions in 2021

    • Figure China Anti-Ageing Drugs Production Share by Regions in 2027

    • Table China Anti-Ageing Drugs Consumption by Regions

    • Table China Anti-Ageing Drugs Consumption Share by Regions

    • Figure China Anti-Ageing Drugs Consumption Share by Regions in 2016

    • Figure China Anti-Ageing Drugs Consumption Share by Regions in 2021

    • Figure China Anti-Ageing Drugs Consumption Share by Regions in 2027

    • Table North China Anti-Ageing Drugs Consumption by Types from 2016 to 2027

    • Table North China Anti-Ageing Drugs Consumption Share by Types from 2016 to 2027

    • Figure North China Anti-Ageing Drugs Consumption Share by Types in 2016

    • Figure North China Anti-Ageing Drugs Consumption Share by Types in 2021

    • Figure North China Anti-Ageing Drugs Consumption Share by Types in 2027

    • Table North China Anti-Ageing Drugs Consumption by End-Users from 2016 to 2027

    • Table North China Anti-Ageing Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure North China Anti-Ageing Drugs Consumption Share by End-Users in 2016

    • Figure North China Anti-Ageing Drugs Consumption Share by End-Users in 2021

    • Figure North China Anti-Ageing Drugs Consumption Share by End-Users in 2027

    • Table Central China Anti-Ageing Drugs Consumption by Types from 2016 to 2027

    • Table Central China Anti-Ageing Drugs Consumption Share by Types from 2016 to 2027

    • Figure Central China Anti-Ageing Drugs Consumption Share by Types in 2016

    • Figure Central China Anti-Ageing Drugs Consumption Share by Types in 2021

    • Figure Central China Anti-Ageing Drugs Consumption Share by Types in 2027

    • Table Central China Anti-Ageing Drugs Consumption by End-Users from 2016 to 2027

    • Table Central China Anti-Ageing Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Anti-Ageing Drugs Consumption Share by End-Users in 2016

    • Figure Central China Anti-Ageing Drugs Consumption Share by End-Users in 2021

    • Figure Central China Anti-Ageing Drugs Consumption Share by End-Users in 2027

    • Table South China Anti-Ageing Drugs Consumption by Types from 2016 to 2027

    • Table South China Anti-Ageing Drugs Consumption Share by Types from 2016 to 2027

    • Figure South China Anti-Ageing Drugs Consumption Share by Types in 2016

    • Figure South China Anti-Ageing Drugs Consumption Share by Types in 2021

    • Figure South China Anti-Ageing Drugs Consumption Share by Types in 2027

    • Table South China Anti-Ageing Drugs Consumption by End-Users from 2016 to 2027

    • Table South China Anti-Ageing Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South China Anti-Ageing Drugs Consumption Share by End-Users in 2016

    • Figure South China Anti-Ageing Drugs Consumption Share by End-Users in 2021

    • Figure South China Anti-Ageing Drugs Consumption Share by End-Users in 2027

    • Table East China Anti-Ageing Drugs Consumption by Types from 2016 to 2027

    • Table East China Anti-Ageing Drugs Consumption Share by Types from 2016 to 2027

    • Figure East China Anti-Ageing Drugs Consumption Share by Types in 2016

    • Figure East China Anti-Ageing Drugs Consumption Share by Types in 2021

    • Figure East China Anti-Ageing Drugs Consumption Share by Types in 2027

    • Table East China Anti-Ageing Drugs Consumption by End-Users from 2016 to 2027

    • Table East China Anti-Ageing Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure East China Anti-Ageing Drugs Consumption Share by End-Users in 2016

    • Figure East China Anti-Ageing Drugs Consumption Share by End-Users in 2021

    • Figure East China Anti-Ageing Drugs Consumption Share by End-Users in 2027

    • Table Northeast China Anti-Ageing Drugs Consumption by Types from 2016 to 2027

    • Table Northeast China Anti-Ageing Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Anti-Ageing Drugs Consumption Share by Types in 2016

    • Figure Northeast China Anti-Ageing Drugs Consumption Share by Types in 2021

    • Figure Northeast China Anti-Ageing Drugs Consumption Share by Types in 2027

    • Table Northeast China Anti-Ageing Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast China Anti-Ageing Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Anti-Ageing Drugs Consumption Share by End-Users in 2016

    • Figure Northeast China Anti-Ageing Drugs Consumption Share by End-Users in 2021

    • Figure Northeast China Anti-Ageing Drugs Consumption Share by End-Users in 2027

    • Table Southwest China Anti-Ageing Drugs Consumption by Types from 2016 to 2027

    • Table Southwest China Anti-Ageing Drugs Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Anti-Ageing Drugs Consumption Share by Types in 2016

    • Figure Southwest China Anti-Ageing Drugs Consumption Share by Types in 2021

    • Figure Southwest China Anti-Ageing Drugs Consumption Share by Types in 2027

    • Table Southwest China Anti-Ageing Drugs Consumption by End-Users from 2016 to 2027

    • Table Southwest China Anti-Ageing Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Anti-Ageing Drugs Consumption Share by End-Users in 2016

    • Figure Southwest China Anti-Ageing Drugs Consumption Share by End-Users in 2021

    • Figure Southwest China Anti-Ageing Drugs Consumption Share by End-Users in 2027

    • Table Northwest China Anti-Ageing Drugs Consumption by Types from 2016 to 2027

    • Table Northwest China Anti-Ageing Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Anti-Ageing Drugs Consumption Share by Types in 2016

    • Figure Northwest China Anti-Ageing Drugs Consumption Share by Types in 2021

    • Figure Northwest China Anti-Ageing Drugs Consumption Share by Types in 2027

    • Table Northwest China Anti-Ageing Drugs Consumption by End-Users from 2016 to 2027

    • Table Northwest China Anti-Ageing Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Anti-Ageing Drugs Consumption Share by End-Users in 2016

    • Figure Northwest China Anti-Ageing Drugs Consumption Share by End-Users in 2021

    • Figure Northwest China Anti-Ageing Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of BIOTIME

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOTIME

    • Figure Sales and Growth Rate Analysis of BIOTIME

    • Figure Revenue and Market Share Analysis of BIOTIME

    • Table Product and Service Introduction of BIOTIME

    • Table Company Profile and Development Status of La Roche-Posay

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of La Roche-Posay

    • Figure Sales and Growth Rate Analysis of La Roche-Posay

    • Figure Revenue and Market Share Analysis of La Roche-Posay

    • Table Product and Service Introduction of La Roche-Posay

    • Table Company Profile and Development Status of Elysium Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elysium Health

    • Figure Sales and Growth Rate Analysis of Elysium Health

    • Figure Revenue and Market Share Analysis of Elysium Health

    • Table Product and Service Introduction of Elysium Health

    • Table Company Profile and Development Status of Nu Skin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nu Skin

    • Figure Sales and Growth Rate Analysis of Nu Skin

    • Figure Revenue and Market Share Analysis of Nu Skin

    • Table Product and Service Introduction of Nu Skin

    • Table Company Profile and Development Status of DermaFix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DermaFix

    • Figure Sales and Growth Rate Analysis of DermaFix

    • Figure Revenue and Market Share Analysis of DermaFix

    • Table Product and Service Introduction of DermaFix


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.